{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:09:47Z","timestamp":1790096987061,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"DOI":"10.1007\/s00066-026-02601-5","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:40:28Z","timestamp":1790095228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re-irradiation using boron neutron capture therapy for recurrent oral squamous cell carcinoma: the impact of tumor volume and early response on survival"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-0768","authenticated-orcid":false,"given":"Kanako","family":"Takayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Takagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Motoyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Takai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2601_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray\u00a0F, Laversanne\u00a0M, Sung\u00a0H, Ferlay\u00a0J, Siegel\u00a0RL, Soerjomataram\u00a0I, Jemal\u00a0A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"2601_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.radonc.2014.04.018","volume":"111","author":"F Duprez","year":"2014","unstructured":"Duprez\u00a0F, Berwouts\u00a0D, Madani\u00a0I, Bonte\u00a0K, Boterberg\u00a0T, De Gersem\u00a0W, Deron\u00a0P, Huvenne\u00a0W, De Neve\u00a0W (2014) High-dose re-irradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival, and toxicity. Clin Transl Radiat Oncol 111:388\u2013392. https:\/\/doi.org\/10.1016\/j.radonc.2014.04.018","journal-title":"Radiother Oncol"},{"key":"2601_CR3","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","volume":"25","author":"CJ Langer","year":"2007","unstructured":"Langer\u00a0CJ, Harris\u00a0J, Horwitz\u00a0EM, Nicolaou\u00a0K, Kies\u00a0JA, Curran\u00a0WJ Jr, Machtay\u00a0M (2007) Phase\u00a0II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily re-irradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J\u00a0Clin Oncol 25:4800\u20134805. https:\/\/doi.org\/10.1200\/JCO.2006.07.9194","journal-title":"J Clin Oncol"},{"key":"2601_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00066-010-2082-9","volume":"186","author":"B Berger","year":"2010","unstructured":"Berger\u00a0B, Belka\u00a0C, Weinmann\u00a0M, Bamberg\u00a0M, Budach\u00a0A (2010) Re-irradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a\u00a0single-center prospective phase\u00a0II protocol. Strahlenther Onkol 186:255\u2013261. https:\/\/doi.org\/10.1007\/s00066-010-2082-9","journal-title":"Strahlenther Onkol"},{"key":"2601_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00066-011-0040-9","volume":"188","author":"L Vormittag","year":"2012","unstructured":"Vormittag\u00a0L, Lemaire\u00a0C, Radonjic\u00a0D, Kuten\u00a0P, Coche-Dequeant\u00a0P (2012) Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck: a\u00a0prospective phase\u00a0II trial. Strahlenther Onkol 188:235\u2013242. https:\/\/doi.org\/10.1007\/s00066-011-0040-9","journal-title":"Strahlenther Onkol"},{"key":"2601_CR6","first-page":"1","volume":"36","author":"GL Locher","year":"1936","unstructured":"Locher\u00a0GL (1936) Biological effects and therapeutic possibilities of neutrons. Am J Roentgenol 36:1\u20133","journal-title":"Am J Roentgenol"},{"key":"2601_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/0955300031000073392","volume":"151","author":"JA Coderre","year":"1999","unstructured":"Coderre\u00a0JA, Morris\u00a0GM (1999) The radiation biology of boron neutron capture therapy. Radiat Res 151:1\u201318. https:\/\/doi.org\/10.1080\/0955300031000073392","journal-title":"Radiat Res"},{"key":"2601_CR8","volume-title":"Advances in boron neutron capture therapy","author":"International Atomic Energy Agency","year":"2023","unstructured":"International Atomic Energy Agency (2023) Advances in boron neutron capture therapy. International Atomic Energy Agency, Vienna"},{"key":"2601_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25040828","volume":"25","author":"F Ali","year":"2020","unstructured":"Ali\u00a0F, Hosmane\u00a0NS, Zhu\u00a0Y (2020) Boron chemistry for medical applications. Molbank 25:828. https:\/\/doi.org\/10.3390\/molecules25040828","journal-title":"Molecules"},{"key":"2601_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/cas.12602","volume":"106","author":"P Wongthai","year":"2015","unstructured":"Wongthai\u00a0P, Hagiwara\u00a0K, Miyoshi\u00a0Y, Yamasaki\u00a0H, Lwin\u00a0T, Okazaki\u00a0H, Ishiguro\u00a0S, Ueda\u00a0S, Kanai\u00a0Y, Endou\u00a0H (2015) Boronophenylalanine, a\u00a0boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1, and LAT2. Cancer Sci 106:279\u2013286. https:\/\/doi.org\/10.1111\/cas.12602","journal-title":"Cancer Sci"},{"key":"2601_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4251\/wjgo.v9.i1.21","volume":"9","author":"K Hayashi","year":"2017","unstructured":"Hayashi\u00a0K, Anzai\u00a0N (2017) Novel therapeutic approaches targeting L\u2011type amino acid transporters for cancer treatment. World J Gastrointest Oncol 9:21\u201329. https:\/\/doi.org\/10.4251\/wjgo.v9.i1.21","journal-title":"World J Gastrointest Oncol"},{"key":"2601_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/jrr\/rrt098","volume":"55","author":"M Suzuki","year":"2014","unstructured":"Suzuki\u00a0M, Kato\u00a0I, Aihara\u00a0T, Hiratsuka\u00a0Y, Sakurai\u00a0Y, Ono\u00a0K (2014) Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. J\u00a0Radiat Res 55:146\u2013153. https:\/\/doi.org\/10.1093\/jrr\/rrt098","journal-title":"J Radiat Res"},{"key":"2601_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.apradiso.2004.05.059","volume":"61","author":"I Kato","year":"2004","unstructured":"Kato\u00a0I, Ono\u00a0K, Sakurai\u00a0Y, Ohmae\u00a0Y, Maruhashi\u00a0Y, Imahori\u00a0T (2004) Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61:1069\u20131073. https:\/\/doi.org\/10.1016\/j.apradiso.2004.05.059","journal-title":"Appl Radiat Isot"},{"key":"2601_CR14","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.nimb.2009.03.095","volume":"267","author":"H Tanaka","year":"2009","unstructured":"Tanaka\u00a0H, Sakurai\u00a0Y, Suzuki\u00a0A, Kobayashi\u00a0T (2009) Characteristics comparison between a cyclotron-based neutron source and KUR-HWNIF for boron neutron capture therapy. Nucl Instrum Methods Phys Res B 267:1970\u20131977","journal-title":"Nucl Instrum Methods Phys Res B"},{"key":"2601_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0167-8140(94)90101-5","volume":"32","author":"GM Morris","year":"1994","unstructured":"Morris\u00a0GM, Coderre\u00a0JA, Hopewell\u00a0JW, Micca\u00a0PL (1994) Response of rat skin to boron neutron capture therapy with p\u2011boronophenylalanine or borocaptate sodium. Radiother Oncol 32:144\u2013153. https:\/\/doi.org\/10.1016\/0167-8140(94)90101-5","journal-title":"Radiother Oncol"},{"key":"2601_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01968-2","volume":"16","author":"N Hu","year":"2021","unstructured":"Hu\u00a0N, Tanaka\u00a0H, Kakino\u00a0R, Yoshioka\u00a0S, Suzuki\u00a0M, Aihara\u00a0T (2021) Evaluation of a\u00a0treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system. Radiat Oncol 16:243. https:\/\/doi.org\/10.1186\/s13014-021-01968-2","journal-title":"Radiat Oncol"},{"key":"2601_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2307\/3578136","volume":"128","author":"J Hiratsuka","year":"1991","unstructured":"Hiratsuka\u00a0J, Fukuda\u00a0H, Kobayashi\u00a0T, Karashima\u00a0S (1991) The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster. Radiat Res 128:186\u2013191","journal-title":"Radiat Res"},{"key":"2601_CR18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/0360-3016(93)90533-2","volume":"27","author":"JA Coderre","year":"1993","unstructured":"Coderre\u00a0JA, Makar\u00a0MS, Micca\u00a0PL, Nawrocky\u00a0JA, Joel\u00a0RG (1993) Derivations of relative biological effectiveness for the high-LET radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo. Int J Radiat Oncol Biol Phys 27:1121\u20131129. https:\/\/doi.org\/10.1016\/0360-3016(93)90533-2","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2601_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2307\/3578693","volume":"138","author":"H Fukuda","year":"1994","unstructured":"Fukuda\u00a0H, Hiratsuka\u00a0J, Honda\u00a0C, Kobayashi\u00a0Y (1994) Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radiat Res 138:435\u2013442","journal-title":"Radiat Res"},{"key":"2601_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2307\/3580083","volume":"152","author":"JA Coderre","year":"1999","unstructured":"Coderre\u00a0JA, Morris\u00a0GM, Kalef-Ezra\u00a0J, Micca\u00a0PL (1999) The effects of boron neutron capture irradiation on oral mucosa: evaluation using a\u00a0rat tongue model. Radiat Res 152:113\u2013118","journal-title":"Radiat Res"},{"key":"2601_CR21","volume-title":"Advances in boron neutron capture therapy","author":"K Ono","year":"2023","unstructured":"Ono\u00a0K (2023) Two-step rate infusion of 4\u2011borono-L-phenylalanine (BPA) solution in BPA-BNCT (Ono\u2019s method). In: Advances in boron neutron capture therapy. International Atomic Energy Agency, Vienna"},{"key":"2601_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JNR-220037","volume":"24","author":"N Hu","year":"2022","unstructured":"Hu\u00a0N, Tanaka\u00a0H, Akita\u00a0K, Yoshioka\u00a0S, Aihara\u00a0T (2022) Accelerator-based epithermal neutron source for clinical boron neutron capture therapy. J\u00a0Neutron Res 24:359\u2013366. https:\/\/doi.org\/10.3233\/JNR-220037","journal-title":"J Neutron Res"},{"key":"2601_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","volume":"359","author":"JB Vermorken","year":"2008","unstructured":"Vermorken\u00a0JB, Mesia\u00a0R, Rivera\u00a0F, Remenar\u00a0E, Kawecki\u00a0A, Rottey\u00a0S et\u00a0al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116\u20131127. https:\/\/doi.org\/10.1056\/NEJMoa0802656","journal-title":"N Engl J Med"},{"key":"2601_CR24","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris\u00a0RL, Blumenschein\u00a0G Jr, Fayette\u00a0J, Guigay\u00a0J, Colevas\u00a0AD et\u00a0al (2016) Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 375:1856\u20131867. https:\/\/doi.org\/10.1056\/NEJMoa1602252","journal-title":"N Engl J Med"},{"key":"2601_CR25","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness\u00a0B, Harrington\u00a0KJ, Greil\u00a0R, Souli\u00e8res\u00a0J, Tahara\u00a0M et\u00a0al (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet 394:1915\u20131928. https:\/\/doi.org\/10.1016\/S0140-6736(19)32591-7","journal-title":"Lancet"},{"key":"2601_CR26","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1002\/hed.26885","volume":"43","author":"DM Cognetti","year":"2021","unstructured":"Cognetti\u00a0DM, Johnson\u00a0JM, Curry\u00a0JM, Kochuparambil\u00a0R et\u00a0al (2021) Phase 1\/2a study of RM-1929 photoimmunotherapy in patients with recurrent head and neck cancer. Head Neck 43:3875\u20133887. https:\/\/doi.org\/10.1002\/hed.26885","journal-title":"Head Neck"},{"key":"2601_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.radonc.2020.11.001","volume":"155","author":"K Hirose","year":"2021","unstructured":"Hirose\u00a0K, Konno\u00a0A, Hiratsuka\u00a0J, Aihara\u00a0T, Tanaka\u00a0H (2021) Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002). Clin Transl Radiat Oncol 155:182\u2013187. https:\/\/doi.org\/10.1016\/j.radonc.2020.11.001","journal-title":"Radiother Oncol"},{"key":"2601_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7250","volume":"13","author":"S Takeno","year":"2024","unstructured":"Takeno\u00a0S, Yoshino\u00a0Y, Aihara\u00a0T, Sato\u00a0M (2024) Preliminary outcomes of boron neutron capture therapy for head and neck cancers as a treatment covered by public health insurance system in Japan. Cancer Med 13:e7250. https:\/\/doi.org\/10.1002\/cam4.7250","journal-title":"Cancer Med"},{"key":"2601_CR29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ijrobp.2024.03.041","volume":"120","author":"K Hirose","year":"2024","unstructured":"Hirose\u00a0K, Sato\u00a0M (2024) Clinical results and prognostic factors in boron neutron capture therapy for recurrent squamous cell carcinoma of the head and neck under the Japan National Health Insurance System. Adv Radiat Oncol 120:796\u2013804. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.03.041","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2601_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050869","volume":"16","author":"M Sato","year":"2024","unstructured":"Sato\u00a0M, Hirose\u00a0K, Takeno\u00a0S (2024) Safety of boron neutron capture therapy with borofalan(10B) and its efficacy on recurrent head and neck cancer. Cancers 16:869. https:\/\/doi.org\/10.3390\/cancers16050869","journal-title":"Cancers (Basel)"},{"key":"2601_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110382","volume":"198","author":"M Sato","year":"2024","unstructured":"Sato\u00a0M, Hirose\u00a0K (2024) Efficacy and safety of boron neutron capture therapy for hypopharyngeal\/laryngeal cancer patients with previous head and neck irradiation. Clin Transl Radiat Oncol 198:110382. https:\/\/doi.org\/10.1016\/j.radonc.2024.110382","journal-title":"Radiother Oncol"},{"key":"2601_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.anl.2024.06.007","volume":"51","author":"M Higashino","year":"2024","unstructured":"Higashino\u00a0M, Aihara\u00a0T, Takeno\u00a0S, Yoshino\u00a0Y (2024) Boron neutron capture therapy as a\u00a0larynx-preserving treatment for locally recurrent laryngeal carcinoma after conventional radiation therapy. Auris Nasus Larynx 51:792\u2013796. https:\/\/doi.org\/10.1016\/j.anl.2024.06.007","journal-title":"Auris Nasus Larynx"},{"key":"2601_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1735487","volume":"16","author":"Y Yoshino","year":"2026","unstructured":"Yoshino\u00a0Y, Takeno\u00a0S, Aihara\u00a0T (2026) Clinical outcomes of boron neutron capture therapy for unresectable oral cancer: a retrospective analysis. Front Oncol 16:1735487. https:\/\/doi.org\/10.3389\/fonc.2026.1735487","journal-title":"Front Oncol"},{"key":"2601_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.apradiso.2015.08.007","volume":"106","author":"T Aihara","year":"2015","unstructured":"Aihara\u00a0T, Hiratsuka\u00a0J, Sakurai\u00a0Y, Tanaka\u00a0H (2015) Fatal carotid blowout syndrome after BNCT for head and neck cancers. Appl Radiat Isot 106:202\u2013206. https:\/\/doi.org\/10.1016\/j.apradiso.2015.08.007","journal-title":"Appl Radiat Isot"},{"key":"2601_CR35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4103\/jcrt.jcrt_2743_23","volume":"21","author":"Y Zhang","year":"2025","unstructured":"Zhang\u00a0Y, Cheng\u00a0Y (2025) Side effects of boron neutron capture therapy. J\u00a0Cancer Res Ther 21:777\u2013786. https:\/\/doi.org\/10.4103\/jcrt.jcrt_2743_23","journal-title":"J Cancer Res Ther"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02601-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:40:30Z","timestamp":1790095230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-026-02601-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":35,"alternative-id":["2601"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02601-5","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.\u00a0Takayama has received speaking and lecture fees from Sumitomo Heavy Industries, Ltd. I.\u00a0Seto, T.\u00a0Ono, Y.\u00a0Takagawa, S.\u00a0Komori, R.\u00a0Kato, A.\u00a0Takeuchi, Y.\u00a0Yamazaki, T.\u00a0Motoyanagi, Y.\u00a0Narita, S.\u00a0Komatsu, T.\u00a0Kato and Y.\u00a0Takai declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Southern Tohoku General Hospital (Approval No. 726) and was conducted in accordance with the Declaration of Helsinki. The requirement for written informed consent was waived due to the retrospective nature of the study, and an opt-out approach was adopted.","order":3,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}}]}}